
Sign up to save your podcasts
Or


A new treatment for malaria in babies and very small children has just been approved; we hear more about the drug expected to save many lives.
Also in the programme: is Israel's new plan to create a so-called “humanitarian city” for Palestinians in Gaza from where they could “voluntarily” emigrate, actually legal? And a report on the environmental damage caused by China's rare earth mineral industry.
(IMAGE: The company logo is seen at the new cell and gene therapy factory of Swiss drugmaker Novartis in Stein, Switzerland, November 28, 2019. Novartis developed the new anti-malaria drug known as Coartem Baby or Riamet Baby in collaboration with the Medicines for Malaria Venture (MMV), a Swiss-based not-for-profit organisation initially backed by the British, Swiss and Dutch Governments, as well as the World Bank and the Rockefeller Foundation / IMAGE: Reuters / Arnd Wiegmann)
By BBC World Service4.2
937937 ratings
A new treatment for malaria in babies and very small children has just been approved; we hear more about the drug expected to save many lives.
Also in the programme: is Israel's new plan to create a so-called “humanitarian city” for Palestinians in Gaza from where they could “voluntarily” emigrate, actually legal? And a report on the environmental damage caused by China's rare earth mineral industry.
(IMAGE: The company logo is seen at the new cell and gene therapy factory of Swiss drugmaker Novartis in Stein, Switzerland, November 28, 2019. Novartis developed the new anti-malaria drug known as Coartem Baby or Riamet Baby in collaboration with the Medicines for Malaria Venture (MMV), a Swiss-based not-for-profit organisation initially backed by the British, Swiss and Dutch Governments, as well as the World Bank and the Rockefeller Foundation / IMAGE: Reuters / Arnd Wiegmann)

7,913 Listeners

4,225 Listeners

3,447 Listeners

523 Listeners

1,079 Listeners

296 Listeners

5,576 Listeners

1,808 Listeners

2,113 Listeners

357 Listeners

201 Listeners

746 Listeners

52 Listeners

227 Listeners

346 Listeners

293 Listeners

235 Listeners

2,592 Listeners

326 Listeners

3,245 Listeners

73 Listeners

689 Listeners

528 Listeners

302 Listeners

630 Listeners

394 Listeners

239 Listeners

54 Listeners

80 Listeners

96 Listeners